rhodium has been researched along with Neoplasms in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (8.70) | 18.7374 |
1990's | 1 (4.35) | 18.2507 |
2000's | 3 (13.04) | 29.6817 |
2010's | 10 (43.48) | 24.3611 |
2020's | 7 (30.43) | 2.80 |
Authors | Studies |
---|---|
Geisler, H; Harringer, S; Jakupec, MA; Kandioller, W; Keppler, BK; Urban, R; Wenisch, D | 1 |
Chae, SY; Gil, YG; Jang, H; Kang, S; Kim, S; Kim, YK; Min, DH; Yim, G | 1 |
Bythell, BJ; Cimatu, KLA; Erasquin, U; Skelton, E; Sukul, A; White, J; Zuercher, A | 1 |
Chen, ZF; Gu, YQ; Hu, MQ; Li, HQ; Liang, H; Ma, MX; Yang, K; Yang, QY | 1 |
Chou, T; Hu, W; Ren, L; Sun, J; Wang, H; Wang, J; Wang, Y; Zhang, B; Zhang, Q | 1 |
Peng, YB; Tan, CP; Tao, C; Zhao, P | 1 |
Bailis, JM; Barton, JK; Dai, J; Nano, A | 1 |
Chen, S; Hong, X; Li, LP; Lu, X; Ma, FE; Ni, QL; Pan, YM; Peng, Y; Wu, YM; Yang, JM; Zhang, Y | 1 |
Barton, JK; Boyle, KM | 1 |
Bandow, JE; Cheng, X; Dabiri, Y; Hager, L; Keppler, BK; Ott, I; Prochnow, P; Streciwilk, W; Terenzi, A; Wölfl, S | 1 |
Brewer, KJ; Rodríguez-Corrales, JÁ; Wang, J; Winkel, BSJ | 1 |
Casari, I; Desai, NM; Falasca, M; Massi, M; Simpson, PV | 1 |
Lai, XY; Liu, YT; Wang, X; Yin, X | 1 |
Sadler, PJ; Zou, T | 1 |
Arun, Y; Balachandran, C; Emi, N; Mayakrishnan, S; Muralidharan, D; Perumal, PT | 1 |
Cieslak, M; Donevski, S; Kazmierczak-Baranska, J; Lorenz, IP; Nawrot, B; Rohbogner, CJ; Wirth, S | 1 |
Hartinger, CG | 1 |
FRUIN, RC; LITTMAN, A; LITTMAN, MS | 1 |
Mora, A; Moya, SA; Pastene, R; Perez, C; Rencoret, G; Sariego, R; Sartori, R | 1 |
Chunfu, Z; Xiuli, Z; Yongping, Z; Yongxian, W | 1 |
Bernhardt, P; Forssell-Aronsson, E; Jacobsson, L; Skarnemark, G | 1 |
Anagnostopoulou, A; Katsaros, N | 1 |
Mitchener, M; Schroeder, HA | 1 |
3 review(s) available for rhodium and Neoplasms
Article | Year |
---|---|
Metal-based antitumor compounds: beyond cisplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Copper; Drug Discovery; Gold; Humans; Iridium; Iron; Metals; Neoplasms; Organometallic Compounds; Rhenium; Rhodium; Ruthenium | 2019 |
Speciation of precious metal anti-cancer complexes by NMR spectroscopy.
Topics: Animals; Antineoplastic Agents; Coordination Complexes; Gold; Humans; Magnetic Resonance Spectroscopy; Metals, Heavy; Neoplasms; Platinum; Rhodium | 2015 |
Rhodium and its compounds as potential agents in cancer treatment.
Topics: Animals; Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Organometallic Compounds; Radioisotopes; Rhodium | 2002 |
20 other study(ies) available for rhodium and Neoplasms
Article | Year |
---|---|
Systematic Study on the Cytotoxic Potency of Commonly Used Dimeric Metal Precursors in Human Cancer Cell Lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Iridium; Neoplasms; Osmium; Rhodium; Ruthenium | 2022 |
Rhodium-Tellurium Nanorod Synthesis Using Galvanic Replacement-Polyol Regrowth for Thermo-Dynamic Dual-Modal Cancer Phototherapy.
Topics: Animals; Mice; Mice, Inbred BALB C; Nanotubes; Neoplasms; Phototherapy; Polymers; Rhodium; Tellurium | 2022 |
Visible Light-Assisted Coordination of a Rh(III)-BODIPY Complex to Guanine.
Topics: Chlorides; Guanine; Humans; Light; Neoplasms; Rhodium | 2023 |
In vitro and in vivo anticancer activity of novel Rh(III) and Pd(II) complexes with pyrazolopyrimidine derivatives.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Coordination Complexes; Mice; Neoplasms; Palladium; Rhodium | 2023 |
A Porous Au@Rh Bimetallic Core-Shell Nanostructure as an H
Topics: Alloys; Animals; Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Cell Membrane Permeability; Gold; Humans; Hydrogen Peroxide; Indicators and Reagents; Indocyanine Green; Metal Nanoparticles; Mice; Multimodal Imaging; Neoplasms; Optical Imaging; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Porosity; Rhodium; Tumor Hypoxia | 2020 |
Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Proliferation; Coordination Complexes; Humans; Mitochondria; Molecular Structure; Neoplasms; Reactive Oxygen Species; Rhodium; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Rhodium Complexes Targeting DNA Mismatches as a Basis for New Therapeutics in Cancers Deficient in Mismatch Repair.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; DNA; DNA Mismatch Repair; Humans; Molecular Structure; Necrosis; Neoplasms; Rhodium | 2021 |
Preparation of Rhodium(III) complexes with 2(1H)-quinolinone derivatives and evaluation of their in vitro and in vivo antitumor activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Mice; Models, Molecular; Neoplasms; Phosphorylation; Quinolones; Rhodium; Xenograft Model Antitumor Assays | 2018 |
A Family of Rhodium Complexes with Selective Toxicity toward Mismatch Repair-Deficient Cancers.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Coordination Complexes; DNA; DNA Mismatch Repair; HCT116 Cells; Humans; Neoplasms; Rhodium | 2018 |
Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorescent Dyes; G-Quadruplexes; Humans; Intercalating Agents; Ligands; Naphthalimides; Neoplasms; Organometallic Compounds; Rhodium; Ruthenium | 2018 |
Mechanistic Investigation into DNA Modification by a Ru
Topics: Antineoplastic Agents; DNA; Humans; Light; Neoplasms; Oxygen; Photochemotherapy; Photolysis; Photosensitizing Agents; Rhodium; Ruthenium; Tumor Hypoxia | 2018 |
Theoretical insight into the photophysical properties of long-lifetime Ir(iii) and Rh(iii) complexes for two-photon photodynamic therapy.
Topics: Benzimidazoles; Coordination Complexes; Humans; Iridium; Models, Molecular; Neoplasms; Photochemotherapy; Photosensitizing Agents; Pyridines; Quantum Theory; Rhodium | 2019 |
Synthesis of cinnolines via Rh(iii)-catalysed dehydrogenative C-H/N-H functionalization: aggregation induced emission and cell imaging.
Topics: Alkynes; Catalysis; Cell Line, Tumor; Cell Survival; Fluorescence; Heterocyclic Compounds, 2-Ring; Humans; Hydrogenation; Indazoles; Models, Molecular; Molecular Imaging; Molecular Structure; Neoplasms; Organometallic Compounds; Phthalazines; Rhodium | 2016 |
Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
Topics: Antineoplastic Agents; Caspase 3; Caspase 7; Cell Death; Cell Line, Tumor; Cells, Cultured; Circular Dichroism; Coordination Complexes; Crystallography, X-Ray; DNA; HeLa Cells; Humans; Iridium; Models, Molecular; Naphthoquinones; Neoplasms; Rhodium | 2010 |
Trapping unstable benzoquinone analogues by coordination to a [(η(5)-C(5)Me(5))Ir] fragment and the anticancer activity of the resulting complexes.
Topics: Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Coordination Complexes; Humans; Iridium; Neoplasms; Rhodium | 2010 |
INTRAGASTRIC BETA-IRRADIATION WITH RUTHENIUM- RHODIUM106 IN PATIENTS WITH PEPTIC ULCER AND GASTRIC NEOPLASM.
Topics: Humans; Neoplasms; Peptic Ulcer; Rhodium; Ruthenium; Stomach Neoplasms; Stomach Ulcer | 1963 |
The novel use of Rh(I) complexes with naphthyridine ligands and poly(oxyethylene) as antitumorals.
Topics: Animals; Antineoplastic Agents; Drug Carriers; Drug Combinations; Drug Screening Assays, Antitumor; Female; Mice; Naphthyridines; Neoplasms; Polyethylene Glycols; Rhodium; Tumor Cells, Cultured | 1996 |
Cyclotron production of no-carrier-added palladium-103 by bombardment of rhodium-103 target.
Topics: Brachytherapy; Chromatography, Ion Exchange; Cyclotrons; Humans; Neoplasms; Palladium; Radiopharmaceuticals; Rhodium | 2001 |
Low-energy electron emitters for targeted radiotherapy of small tumours.
Topics: Antimony; Beta Particles; Cobalt Radioisotopes; Computer Simulation; Dose-Response Relationship, Radiation; Drug Delivery Systems; Electrons; Half-Life; Holmium; Humans; Linear Energy Transfer; Models, Theoretical; Neoplasms; Osmium; Photons; Radioisotopes; Rhodium | 2001 |
Scandium, chromium(VI), gallium, yttrium, rhodium, palladium, indium in mice: effects on growth and life span.
Topics: Aging; Animals; Body Weight; Carcinogens; Chromium; Female; Gallium; Growth; Indium; Longevity; Male; Mice; Neoplasms; Palladium; Rats; Rhodium; Scandium; Sex Factors; Tooth; Weaning; Yttrium | 1971 |